Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jan:208:102172.
doi: 10.1016/j.pneurobio.2021.102172. Epub 2021 Sep 4.

Neuroimmune interactions and immunoengineering strategies in peripheral nerve repair

Affiliations
Review

Neuroimmune interactions and immunoengineering strategies in peripheral nerve repair

Kathryn L Wofford et al. Prog Neurobiol. 2022 Jan.

Abstract

Peripheral nerve injuries result in disrupted cellular communication between the central nervous system and somatic distal end targets. The peripheral nervous system is capable of independent and extensive regeneration; however, meaningful target muscle reinnervation and functional recovery remain limited and may result in chronic neuropathic pain and diminished quality of life. Macrophages, the primary innate immune cells of the body, are critical contributors to regeneration of the injured peripheral nervous system. However, in some clinical scenarios, macrophages may fail to provide adequate support with optimal timing, duration, and location. Here, we review the history of immunosuppressive and immunomodulatory strategies to treat nerve injuries. Thereafter, we enumerate the ways in which macrophages contribute to successful nerve regeneration. We argue that implementing macrophage-based immunomodulatory therapies is a promising treatment strategy for nerve injuries across a wide range of clinical presentations.

Keywords: Immunoengineering; Immunomodulation; Macrophages; Peripheral nerve injury; Regeneration.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

DKC is a co-founder and RBS is an employee of Axonova Medical, LLC, which is a University of Pennsylvania spin-out company focused on translation of advanced regenerative therapies to treat nervous system disorders. KLW has filed a patent application related to control of macrophage phenotype via intracellular microparticles (U.S. Patent App. PCT/US18/34906). No other author has declared a potential conflict of interest.

Figures

Figure 1.
Figure 1.. Macrophages contribute to peripheral nerve regeneration.
(A) Macrophages at the dorsal root ganglia release neurotrophic factors such as leukemia inhibitor factor (LIF) that stimulate axonal outgrowth. (B) Macrophages at the distal end target contribute to synapse formation and neurotransmitter regulation. (C-H) Macrophages at the injury site (C) clear myelin fragments and cellular debris, (D) regulate extracellular matrix (ECM) organization through secreting tissue inhibitors of metalloproteinase (TIMPs), (E) stimulate angiogenesis through secretion of vascular endothelial growth factor (VEGF), (F) recruit Schwann cells with chemokine ligand 3 (CCL3), (G) induce Schwann cell maturation through growth arrest specific 6 (GAS6), and (H) prevent ectopic growth with slit homolog 3 protein (Slit3) expression.

Similar articles

Cited by

References

    1. Aguilar Salegio EA, Pollard AN, Smith M, Zhou XF, 2011. Macrophage presence is essential for the regeneration of ascending afferent fibres following a conditioning sciatic nerve lesion in adult rats. BMC Neurosci. 12. doi:10.1186/1471-2202-12-11 - DOI - PMC - PubMed
    1. Akbik F, Cafferty WBJ, Strittmatter SM, 2012. Myelin Associated Inhibitors: A Link Between Injury-Induced and Experience-Dependent Plasticity. Exp. Neurol 235, 43–52. doi:10.1016/j.expneurol.2011.06.006 - DOI - PMC - PubMed
    1. Amann L, Prinz M, 2020. The origin, fate and function of macrophages in the peripheral nervous system-an update. Int. Immunol 32, 709–717. doi:10.1093/intimm/dxaa030 - DOI - PubMed
    1. Anselmo, Gilbert JB, Kumar S, Gupta V, Cohen RE, Rubner MF, Mitragotri S, 2015a. Monocyte-mediated delivery of polymeric backpacks to inflamed tissues: a generalized strategy to deliver drugs to treat inflammation. J. Control. Release 199, 29–36. doi:10.1016/j.jconrel.2014.11.027 - DOI - PubMed
    1. Anselmo, Mitragotri S, 2014. Cell-Mediated Delivery of Nanoparticles: Taking Advantage of Circulatory Cells to Target Nanoparticles. J Control Release 531–541. doi:10.1016/j.micinf.2011.07.011.Innate - DOI - PMC - PubMed

Publication types